Suchergebnisse - "Elamin, Yasir Y"

PubPharm (49)

1

Enhancing NSCLC recurrence prediction with PET/CT habitat imaging, ctDNA, and integrative radiogenomics-blood insights

enthalten in: Nature communications | 2024

von Sujit, S. | Aminu, M. | Karpinets, T. | +34

2

A Novel Multimodal Approach to Refractory Brain Metastases : A Case Report

enthalten in: Advances in radiation oncology | 2024

von Katlowitz, K. | Beckham, T. | Kudchadker, R. | +3

3

HER4 and EGFR Activate Cell Signaling in NRG1 Fusion-Driven Cancers : Implications for HER2-HER3-specific Versus Pan-HER Targeting Strategies

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2024

von Udagawa, H. | Nilsson, M. | Robichaux, J. | +15

4

First-Line Selpercatinib or Chemotherapy and Pembrolizumab in RET Fusion-Positive NSCLC

enthalten in: The New England journal of medicine | 2023

von Zhou, C. | Solomon, B. | Loong, H. | +122

CommentIn: Cancer Discov. 2023 Dec 12;13(12):OF8. - PMID 37874126

5

Stereotactic ablative radiotherapy with or without immunotherapy for early-stage or isolated lung parenchymal recurrent node-negative non-small-cell lung cancer : an open-label, randomised, phase 2 trial

enthalten in: Lancet (London, England) | 2023

von Chang, J. | Lin, S. | Dong, W. | +25

CommentIn: Lancet. 2023 Sep 9;402(10405):829-831. - PMID 37478884

6

Brief Report : Clinical Response, Toxicity, and Resistance Mechanisms to Osimertinib Plus MET Inhibitors in Patients With EGFR-Mutant MET-Amplified NSCLC

enthalten in: JTO clinical and research reports | 2023

von Wang, K. | Du, R. | Roy-Chowdhuri, S. | +22

7

Nivolumab and ipilimumab with concurrent stereotactic radiosurgery for intracranial metastases from non-small cell lung cancer : analysis of the safety cohort for non-randomized, open-label, phase I/II trial

enthalten in: Journal for immunotherapy of cancer | 2023

von Altan, M. | Wang, Y. | Song, J. | +24

ErratumIn: J Immunother Cancer. 2023 Jul;11(7):. - PMID 37487668

8

Predicting benefit from immune checkpoint inhibitors in patients with non-small-cell lung cancer by CT-based ensemble deep learning : a retrospective study

enthalten in: The Lancet. Digital health | 2023

von Saad, M. | Hong, L. | Aminu, M. | +46

CommentIn: Lancet Digit Health. 2023 Jul;5(7):e396-e397. - PMID 37268450

9

Pan-cancer T cell atlas links a cellular stress response state to immunotherapy resistance

enthalten in: Nature medicine | 2023

von Chu, Y. | Dai, E. | Li, Y. | +42

10

Protein Tyrosine Phosphatase Non-Receptor 11 (PTPN11/Shp2) as a Driver Oncogene and a Novel Therapeutic Target in Non-Small Cell Lung Cancer (NSCLC)

enthalten in: International journal of molecular sciences | 2023

von Richards, C. | Elamin, Y. | Carr, A. | +13

1
2
3
4
5
Nächster »
[5]